Rolistobart
Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. Rolistobart is an immunostimulant and antineoplastic[1].
Product Specifications
CAS Number
[2723442-10-0]
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rolistobart.html
Purity
97.78
Solubility
10 mM in DMSO
Smiles
[Rolistobart]
Molecular Weight
(146.62 kDa)
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 36, No. 4, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
250806-ML650 100 µL
RAB43 (RAB43, Member RAS Oncogene Family, ISY1, MGC90481, RAB11B, RAB41) (MaxLight 650)
Sign In for Pricing
View Details 
MBS1035355-01 0.02 mg (E-Coli)
Recombinant Brucella canis Glutamate--tRNA ligase 2 (gltX2)
Sign In for Pricing
View Details